Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Karthick, Rajamanickam"'
Autor:
Sougoumarane Dashnamoorthy, Ebenezar Jeyasingh, VINDHYAVASINI PANDEY, Karthick Rajamanickam, Sachin S Kotur, Durga Prasad Sahoo
Publikováno v:
Iranian Journal of Medical Physics, Vol 21, Iss 1, Pp 16-29 (2024)
Introduction:This study aims to investigate the Normal Tissue Complication Probability (NTCP) and Tumor Control Probability (TCP) of cervical cancer from Niemierko radiobiological model and compared with Lyman-Kutcher-Butcher (LKB) model’s effectiv
Externí odkaz:
https://doaj.org/article/0c8ffef58df443b2a4d148724682252e
Publikováno v:
Reports of Practical Oncology and Radiotherapy. 28:54-65
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ebac0824b52211528f06ab78fba4b47a
https://doi.org/10.5603/rpor.a2023.0002
https://doi.org/10.5603/rpor.a2023.0002
Autor:
Sougoumarane Dashnamoorthy, Karthick Rajamanickam, Ebenezar Jeyasingh, Vindhyavasini Prasad Pandey, Kathiresan Nachimuthu, Imtiaz Ahmed, Pitchaikannu Venkatraman
Publikováno v:
Progress in Medical Physics. 33:25-35
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f1b9fa1dcc10182a142f4021e4a643ec
https://doi.org/10.14316/pmp.2022.33.3.25
https://doi.org/10.14316/pmp.2022.33.3.25
Autor:
Prabakar, Kandasamy, Sivalingam, Periyasamy, Mohamed Rabeek, Siyed Ibrahim, Muthuselvam, Manickam, Devarajan, Naresh, Arjunan, Annavi, Karthick, Rajamanickam, Suresh, Micky Maray, Wembonyama, John Pote
Publikováno v:
In Colloids and Surfaces B: Biointerfaces 1 April 2013 104:282-288
Autor:
Sougoumarane Dashnamoorthy, Karthick Rajamanickam, Pitchaikannu Venkatraman, Vindhyavasini Prasad Pandey, Imtiaz Ahmed, Durga Prasad Sahoo
Publikováno v:
SSRN Electronic Journal.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::18bec80a80c5ee48e560a3e83e61817d
https://doi.org/10.2139/ssrn.4196749
https://doi.org/10.2139/ssrn.4196749
Autor:
Deepti Mishra, Saravana Rajamanickam, Aruna Prabhu, Deepan Rajamanickam, Bhavesh Poladia, Karthick Rajamanickam, N. Kathiresan, C. Shuba
Publikováno v:
Indian Journal of Surgical Oncology. 13:108-109
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::eaf343fe91b6e90f5b1f9d9515084e69
https://doi.org/10.1007/s13193-022-01586-8
https://doi.org/10.1007/s13193-022-01586-8
Autor:
Supriya Chopra, Karishma George, Reena Engineer, Karthick Rajamanickam, Siji Nojin, Kishore Joshi, Jamema Swamidas, Nitin Shetty, Shraddha Patkar, Prachi Patil, Vikas Ostwal, Shaesta Mehta, Mahesh Goel
Publikováno v:
Br J Radiol
Objectives: To evaluate the outcomes of stereotactic radiotherapy (SBRT) in the treatment of inoperable hepatocellular carcinomas (HCC) that are unsuitable for, or refractory to other liver-directed therapies. Methods: Between March 2015 and June 201
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::620251bd9d51de2c5c93a33595718ac8
https://doi.org/10.1259/bjr.20181053
https://doi.org/10.1259/bjr.20181053
Autor:
Supriya Chopra, Nitin Shetty, Mahesh Goel, Reena Engineer, Karthick Rajamanickam, Suyash Kulkarni, Ashwin Polnaya, Shradha Patkar, Vikas Ostwal, Mukta Ramadwar, Jamema Swamidas, Reena Phurailatpam, Siji N. Paul, Epili Dhandpani, Kishore Joshi, Sadhana Kannan, Venkatesh Rangarajan, Shaesta Mehta, Prachi Patil, S. K. Shrivastava
Publikováno v:
International Journal of Clinical Trials. 4:31
Background: Vast majority of patients with hepatocellular carcinoma (HCC) present with unresectable disease. In the last decade results of randomized trials and subsequent meta-analyses established trans-arterial chemoembolization (TACE) as standard
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c5676d36b0a7c73ea8ac36da7f164dc8
https://doi.org/10.18203/2349-3259.ijct20170306
https://doi.org/10.18203/2349-3259.ijct20170306
Autor:
Supriya Chopra, Reena Engineer, Ashwathy Susan Mathew, Shaesta Mehta, Vikas Ostwal, Mahesh Goel, Karthick Rajamanickam, Prachi Patil, Sudeep Gupta, Nitin Shetty, Sadhana Kannan, Ashwin Polnaya, Shraddha Patkar, Venkatesh Rangarajan, Archi Agarwal, Mukta Ramadwar, Shailesh Shrikhande, Kishore Joshi, Epili Dandpani, Shyam Kishore Shrivastava
Publikováno v:
International Journal of Clinical Trials. 4:14
Background: Systemic doublet chemotherapy constitutes the current standard of care for patients with unresectable non-metastatic cholangiocarcinoma. The use of doublet chemotherapy is associated with median survival of 11.7 months. Concurrent chemo-r
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::4f49cda34ccb915bf5e678975e182e0e
https://doi.org/10.18203/2349-3259.ijct20170303
https://doi.org/10.18203/2349-3259.ijct20170303